82 related articles for article (PubMed ID: 19888879)
1. Respiratory delivery of theophylline by size-targeted starch microspheres for treatment of asthma.
Momeni A; Mohammadi MH
J Microencapsul; 2009 Dec; 26(8):701-10. PubMed ID: 19888879
[TBL] [Abstract][Full Text] [Related]
2. Alginate microspheres of isoniazid for oral sustained drug delivery.
Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of glutaraldehyde cross-linked O-carboxymethylchitosan microspheres for controlled delivery of pazufloxacin mesilate.
Liu YF; Huang KL; Peng DM; Ding P; Li GY
Int J Biol Macromol; 2007 Jun; 41(1):87-93. PubMed ID: 17292465
[TBL] [Abstract][Full Text] [Related]
4. Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for pylorospasm.
Sultana S; Bhavna ; Iqbal Z; Panda BP; Talegaonkar S; Bhatnagar A; Ahmad FJ
J Microencapsul; 2009 Aug; 26(5):385-93. PubMed ID: 18720200
[TBL] [Abstract][Full Text] [Related]
5. Preparation of gelatin microspheres containing lactic acid--effect of cross-linking on drug release.
Dinarvand R; Mahmoodi S; Farboud E; Salehi M; Atyabi F
Acta Pharm; 2005 Mar; 55(1):57-67. PubMed ID: 15907224
[TBL] [Abstract][Full Text] [Related]
6. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology.
Emami J; Hamishehkar H; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Mirzadeh H; Fakhari A; Nokhodchi A
J Microencapsul; 2009 Feb; 26(1):1-8. PubMed ID: 18465287
[TBL] [Abstract][Full Text] [Related]
7. Viscosity of polymer solution phase and other factors controlling the dissolution of theophylline microspheres prepared by the emulsion solvent evaporation method.
Obeidat WM; Price JC
J Microencapsul; 2003; 20(1):57-65. PubMed ID: 12519702
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration.
Mathew ST; Devi SG; KV S
AAPS PharmSciTech; 2007 Feb; 8(1):14. PubMed ID: 17408214
[TBL] [Abstract][Full Text] [Related]
9. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
10. Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres.
Gayakwad SG; Bejugam NK; Akhavein N; Uddin NA; Oettinger CE; D'Souza MJ
J Microencapsul; 2009 Dec; 26(8):692-700. PubMed ID: 19888878
[TBL] [Abstract][Full Text] [Related]
11. Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman.
Gupta KC; Jabrail FH
Carbohydr Res; 2006 May; 341(6):744-56. PubMed ID: 16499893
[TBL] [Abstract][Full Text] [Related]
12. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
Shaheen SM; Takezoe K; Yamaura K
Biomed Mater Eng; 2004; 14(4):371-82. PubMed ID: 15472386
[TBL] [Abstract][Full Text] [Related]
13. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.
Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR
Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847
[TBL] [Abstract][Full Text] [Related]
14. Intranasal administration of melatonin starch microspheres.
Mao S; Chen J; Wei Z; Liu H; Bi D
Int J Pharm; 2004 Mar; 272(1-2):37-43. PubMed ID: 15019067
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of uniform-sized chitosan microspheres and application as carriers for protein drugs].
Gu YH; Wang LY; Tan TW; Ma GH
Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):150-5. PubMed ID: 16572856
[TBL] [Abstract][Full Text] [Related]
16. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin.
Anal AK; Stevens WF; Remuñán-López C
Int J Pharm; 2006 Apr; 312(1-2):166-73. PubMed ID: 16497452
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of uniform-sized chitosan microspheres containing insulin by membrane emulsification and a two-step solidification process.
Wang LY; Gu YH; Zhou QZ; Ma GH; Wan YH; Su ZG
Colloids Surf B Biointerfaces; 2006 Jul; 50(2):126-35. PubMed ID: 16787743
[TBL] [Abstract][Full Text] [Related]
18. Novel sustained release microspheres for pulmonary drug delivery.
Cook RO; Pannu RK; Kellaway IW
J Control Release; 2005 May; 104(1):79-90. PubMed ID: 15866336
[TBL] [Abstract][Full Text] [Related]
19. Preparation and improvement of release behavior of chitosan microspheres containing insulin.
Wang LY; Gu YH; Su ZG; Ma GH
Int J Pharm; 2006 Mar; 311(1-2):187-95. PubMed ID: 16436319
[TBL] [Abstract][Full Text] [Related]
20. [Efficiency and safety of anhydrous theophylline in delayed-release microspheres in the treatment of bronchial asthma].
Huerta JG; Moguel A
Rev Alerg Mex (1987); 1988; 35(2):41-6. PubMed ID: 3389490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
